Publication | Closed Access
Hydralazine and magnesium valproate as epigenetic treatment for myelodysplastic syndrome. Preliminary results of a phase-II trial
72
Citations
27
References
2010
Year
Hematological MalignancyEpigenetic TreatmentHematologyPharmacologyMagnesium ValproatePharmacotherapyMedicineEpigeneticsPhase-ii TrialMyeloid Neoplasia
| Year | Citations | |
|---|---|---|
Page 1
Page 1